natgillin/translations-raw huggingface dataset:
There is a need for more effective preventive and therapeutic interventions and vaccines and evidence-based vaccination schemes for an expanded range of diseases, including poverty-related diseases such as HIV/AIDS, tuberculosis, malaria and neglected infectious diseases and also for other major diseases.
Razviti je treba učinkovitejše preventivne in terapevtske posege in cepiva ter na dokazih temelječe programe cepljenja za širši razpon bolezni, vključno z boleznimi, povezanimi z revščino, kot so HIV/AIDS, tuberkuloza, malarija in zapostavljene nalezljive bolezni, pa tudi za druge hude bolezni.
This relies on a better understanding of disease and disease processes and their consequent epidemics and on clinical trials and associated studies being undertaken.
Zato je treba bolje razumeti bolezni in bolezenske procese ter s tem povezane epidemije ter opraviti klinične preskuse in s tem povezane študije.
Treating and managing disease
Zdravljenje in obravnava bolezni
Treating disease, including developing regenerative medicine
Zdravljenje bolezni, vključno z razvojem regenerativne medicine
There is a need to support the improvement of cross-cutting support technologies for drugs, biotherapies, vaccines and other therapeutic approaches, including transplantation, surgery, gene and cell therapy and nuclear medicine;
Treba je podpirati izboljšanje medsektorske podporne tehnologije za zdravila, bioterapije, cepiva in druge terapevtske pristope, vključno s presajanjem organov, kirurgijo, gensko in celično terapijo ter jedrsko medicino;
to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing, e.g. the development of new methods);
zagotoviti uspešnejši razvoj zdravil in cepiv (vključno z alternativnimi metodami, ki bi zamenjale klasično testiranje varnosti in učinkovitosti, na primer z razvojem novih metod);
to develop regenerative medicine approaches, including approaches based on stem cells;
razviti boljše medicinske in podporne pripomočke in sisteme, vključno s pristopi, ki temeljijo na izvornih celicah;
to develop new biopharmaceuticals, including therapeutic vaccines;
razviti nova biološka zdravila, vključno s terapevtskimi cepivi;
to develop improved medical and assistive devices and systems;
razviti boljše medicinske in podporne pripomočke in sisteme;
to improve palliative therapies;
izboljšati paliativne terapije;
These improvements will facilitate the development of new, more efficient, effective, sustainable and personalised treatments for disease and for the management of disability and frailty, including advanced therapies and cellular therapies for the treatment of chronic diseases.
Te izboljšave bodo olajšale razvoj novih, učinkovitejših, uspešnejših, trajnejših in bolj osebnih metod za zdravljenje bolezni ter obravnavanje invalidnosti in slabotnosti, vključno z naprednimi in celičnimi terapijami za zdravljenje kroničnih bolezni.
Transferring knowledge to clinical practice and scalable innovation actions
Prenos znanja v klinično prakso in nadgradljivi inovacijski ukrepi
Clinical trials are an important means to transfer biomedical knowledge to application in patients, and support for these will be provided, as well as for the improvement of their practice.
Podpirali se bodo klinični preskusi, ki so pomemben način za prenos biomedicinskega znanja na uporabo pri pacientih, pa tudi izboljšanje njihove prakse.
Examples include the development of better methodologies to allow trials to focus on relevant population groups, including those suffering from other concomitant diseases and/or already undergoing treatment; the determination of comparative effectiveness of interventions and solutions;
Sem spadajo razvoj boljših metod, da se pri poskusih zagotovi osredotočenost na ustrezne skupine prebivalstva, vključno s tistimi, ki so istočasno zboleli za drugimi bolezni in/ali se že zdravijo, določitev primerljive učinkovitosti posegov in rešitev ter okrepljena uporaba zbirk podatkov in elektronskih zdravstvenih kartotek kot virov podatkov za poskuse in prenos znanja.
and enhancing the use of databases and electronic health records as data sources for trials and knowledge transfer.
Podpiran bo predklinični in klinični razvoj določenih zdravil sirot.
Pre-clinical and/or clinical development of designated orphan drugs will be supported. Similarly, support for the transfer of other types of interventions, such as those related to independent living, into real world environments will be provided.
Podpora bo namenjena tudi prenosu drugih vrst ukrepov, npr. ukrepov za samostojno življenje, v resnično svetovno okolje.
Active ageing and self-management of health
Aktivno staranje in skrb za svoje zdravje
Active ageing and independent and assisted living
Aktivno staranje in samostojno življenje ter pomoč za samostojno življenje
Multidisciplinary advanced and applied research and innovation with socioeconomic, behavioural, gerontological, digital and other sciences is needed for cost-effective user-friendly solutions for active, independent and assisted daily living (in the home, the workplace, public spaces, etc.) for the ageing population and people with disabilities taking into account gender differences.
Za stroškovno učinkovite ter uporabnikom prijazne rešitve za aktivno in samostojno vsakdanje življenje ter pomoč za samostojno življenje (doma, na delovnem mestu, na javnih mestih itd.) starajočega se prebivalstva in invalidov so potrebne večdisciplinarne napredne in uporabne raziskave in inovacije v družbeno-ekonomskih, vedenjskih, gerontoloških, digitalnih in drugih znanostih, ki upoštevajo razlike med spoloma.
This applies in a variety of settings and for technologies and systems and services enhancing quality of life and human functionality including mobility, smart personalised assistive technologies, service and social robotics, and ambient assistive environments.
To velja za različna okolja, tehnologije, sisteme in storitve, ki izboljšujejo kakovost življenja in človeške funkcije, vključno z mobilnostjo, pametnimi prilagojenimi podpornimi tehnologijami, storitveno in socialno robotiko ter podpornim okoljem.
Research and innovation pilots to assess implementation and wide uptake of solutions will be supported.
Podpirali se bodo raziskovalni in inovacijski pilotni projekti, pri katerih se ocenjujeta izvajanje in širša uporaba rešitev.
Involvement of end-users, user communities and formal/informal carers will be emphasised.
Poudarek bo na sodelovanju končnih uporabnikov, uporabniških skupnostih in formalnih/neformalnih skrbnikih.
Individual awareness and empowerment for self-management of health
Ozaveščanje in usposabljanje posameznikov, da sami skrbijo za svoje zdravje
Empowering individuals to improve and manage their health throughout life will result in more cost-effective health and care systems by enabling the management of chronic disease outside institutions and improving health outcomes.
Usposabljanje posameznikov, da sami izboljšajo in skrbijo za svoje zdravje vse življenje, bo z zdravljenjem kroničnih bolezni zunaj zdravstvenih ustanov pripomoglo k stroškovno učinkovitim zdravstvenim sistemom in izboljšalo zdravstvene rezultate.
This requires research into socio-economic factors and cultural values, behavioural and social models, attitudes and aspirations in relation to personalised health technologies, mobile and/or portable tools, new diagnostics, sensors and devices for monitoring and personalised services including but not limited to nanomedicine-based tools which promote a healthy lifestyle, well-being, mental health, self-care, improved citizen/healthcare professional interaction, personalised programmes for disease and disability management to, inter alia, enhance patients' autonomy, as well as support for knowledge infrastructures.
Za to bodo potrebne raziskave družbeno-ekonomskih dejavnikov, kulturnih vrednot, vedenjskih in družbenih modelov, odnosov in pričakovanj družbe v zvezi z osebnimi zdravstvenimi tehnologijami, mobilnimi in/ali prenosnimi napravami, novimi diagnostičnimi postopki, senzorji in napravami za spremljanje ter prilagojenimi storitvami, med drugim z orodji, ki temeljijo na nanomedicini, s katerimi se spodbujajo zdrav način življenja, dobro počutje, duševno zdravje, samopomoč, boljša povezanost med državljani in zdravstvenim sistemom, prilagojeni programi za obravnavo bolezni in invalidnosti, da bi med drugim zagotovili večjo samostojnost bolnikov, ter podpora infrastrukturam znanja.
Solutions will be developed and tested with the use of open innovation platforms such as large-scale demonstrators for social and service innovation.
Rešitve bodo razvijane in preskušane z uporabo odprtih inovativnih platform, kot so večji demonstratorji za socialne in storitvene inovacije.
Methods and data
Metode in podatki
Improving health information and better use of health data
Izboljšanje informacij o zdravju in boljša uporaba podatkov o zdravju
The integration of infrastructures and information structures and sources (including those derived from cohort studies, protocols, data collections, indicators, health examination surveys etc.) as well as the standardisation, interoperability, storage, sharing of and access to data, will be supported to enable such data to be sustainable in the long-term and properly exploited.
Podpora bo namenjena tudi povezovanju infrastruktur, informacijskih struktur in virov (vključno s tistimi iz kohortnih študij, protokolov, zbirk podatkov, kazalnikov, anket o zdravstvenih pregledih itd.) ter standardizaciji, interoperabilnosti, shranjevanju in izmenjavi podatkov ter dostopu do njih, da bi omogočili trajno in dolgoročno ter ustrezno izkoriščanje takih podatkov.
Attention should be given to data processing, knowledge management, modelling, visualisation, ICT-security and privacy-related issues.
Pozornost bi bilo treba nameniti obdelavi podatkov, upravljanju znanja, modeliranju, vizualizaciji, varnosti IKT in vprašanjem, povezanim z zasebnostjo.
In particular, availability of information and data on negative results and adverse effects of treatment need to be improved.
Izboljšati je treba zlasti razpoložljivost informacij in podatkov o negativnih rezultatih in neželenih učinkih zdravljenja.
Improving scientific tools and methods to support policy making and regulatory needs
Izboljšanje znanstvenih orodij in metod v podporo oblikovanju politik in regulativnih potreb
There is a need to support research, development, integration and use of scientific tools, methods and statistics for rapid, accurate and predictive assessment of the safety, efficacy and quality of health interventions and technologies including new drugs, biologics, advanced therapies and medical devices.
Treba je podpreti raziskave, razvoj, vključevanje in uporabo znanstvenih orodij, metod in statističnih podatkov za hitro, natančno in napovedno ocenjevanje varnosti, učinkovitosti in kakovosti zdravstvenih posegov in tehnologij, vključno z novimi zdravili, biološkimi zdravili, naprednimi terapijami in medicinskimi pripomočki.
This is particularly relevant for new developments in domains concerning biopharmaceuticals, vaccines, antimicrobials, cell/tissue and gene therapies, organs and transplantation, specialist manufacturing, biobanks, new medical devices, combination products, diagnostic/treatment procedures, genetic testing, interoperability and e-health, including privacy aspects.
To je zlasti pomembno za nov razvoj na področjih, kot so biološka zdravila, cepiva, protimikrobna sredstva, celične/tkivne in genske terapije, organi in presajanje organov, specializirana proizvodnja, biobanke, novi medicinski pripomočki, kombinirani izdelki, diagnostični/terapevtski postopki, gensko testiranje, interoperabilnost in e-zdravje, vključno z vidiki zasebnosti.
Similarly, support for improved risk assessment methodologies, compliance frameworks, testing approaches and strategies relating to environment and health is required.
Podpirati je treba tudi razvoj metodologij za ocenjevanje tveganja, okvirov za skladnost, pristope glede preskusov ter strategije, povezane z okoljem in zdravjem.
There is also a need to support the development of relevant methods for assisting the assessment of ethical aspects of the above-mentioned domains.
Prav tako je treba podpirati razvoj ustreznih metod za lažje ocenjevanje etičnih vidikov zgoraj navedenih področij.
Using in-silico medicine for improving disease management and prediction
Uporaba zdravil in-silico za boljše obravnavanje in napovedovanje bolezni
Computer simulation-based medical systems using patient-specific data and building on systems medicine approaches and physiological modelling can be used to predict susceptibility to disease, disease evolution and the likely success of medical treatments.
Zdravstveni sistemi, ki temeljijo na računalniških simulacijah, v katerih so uporabljeni posebni podatki o bolnikih, ter na sistemskomedicinskih pristopih in fiziološkem modeliranju, se lahko uporabljajo za napovedovanje dovzetnosti za bolezni, njenega razvoja in verjetnosti uspešnega zdravljenja.
Model-based simulation can be used to support clinical trials, predictability of treatment response, and the personalisation and optimisation of treatment.
Modelno podprta simulacija se lahko uporablja za podpiranje kliničnih preskusov, predvidljivosti odziva na zdravljenje ter personalizacijo in optimizacijo zdravljenja.
Health care provision and integrated care
Zagotavljanje zdravstvenega varstva in celostna oskrba
Promoting integrated care
Spodbujanje celostne oskrbe
Supporting the management of chronic disease, including patients with disabilities, outside institutions also depends on improved cooperation between the providers of health and social or informal care.
Spodbujanje zdravljenja kroničnih bolezni, vključno z invalidnimi bolniki, zunaj zdravstvenih ustanov je odvisno tudi od okrepljenega sodelovanja med ponudniki zdravstvenega in socialnega oziroma neformalnega varstva.
Research and innovative applications will be supported for decision making based on distributed information addressing both physical and mental health, including psychosocial aspects, and for providing evidence for large-scale deployments and market exploitation of novel solutions, including interoperable tele-health and tele-care services.
Podpora bo namenjena raziskavam in inovativnim aplikacijam za odločanje na podlagi porazdeljenih podatkov o fizičnem in duševnem zdravju, vključno s psihosocialnimi vidiki, ter za zagotavljanje dokazov za široko uporabo in trženje novih rešitev, vključno z interoperabilnimi elektronskimi zdravstvenimi storitvami in oskrbo na daljavo.
Particularly in the context of demographic change, research and innovation to improve the organisation of long-term care delivery as well as policy and management innovation will also be supported.
Zlasti v zvezi z demografskimi spremembami se bodo podpirale tudi raziskave in inovacije, s katerimi bo mogoče izboljšati organizacijo dolgoročne oskrbe, pa tudi inovacije v zvezi s politiko in upravljanjem.
Implementing new and integrated care solutions shall aim at personal empowerment and enhancement of existing capabilities as well as concentrate on compensation of deficits.
Cilj uveljavljanja novih in celostnih rešitev glede oskrbe bo osebna izpolnitev in izboljšanje obstoječih sposobnosti ter poudarek na kompenzaciji pomanjkljivosti.
Optimising the efficiency and effectiveness of healthcare provision and reducing inequalities by evidence-based decision making and dissemination of best practice, and innovative technologies and approaches
Izboljšanje učinkovitosti in uspešnosti zdravstvenega varstva in zmanjšanje neenakosti z odločanjem na podlagi dokazov in širjenjem najboljše prakse ter inovativnih tehnologij in pristopov
There is a need to support the development of a systemic approach to health technology assessment and health economics, as well as the gathering of evidence and dissemination of best practice and innovative technologies and approaches in the health and care sector, including ICT and e-health applications.
Podpreti je treba oblikovanje sistematičnega pristopa k ocenjevanju zdravstvenih tehnologij in zdravstvene ekonomike ter zbiranja dokazov, širjenja najboljše prakse ter inovativnih tehnologij in pristopov v zdravstvenem sektorju, vključno z informacijsko-komunikacijskimi tehnologijami in aplikacijami e-zdravja.
Comparative analyses of the reform of public health systems in Europe and in third countries and assessments of their mid- to long-term economic and social impacts will be supported.
Podpirale se bodo primerjalne analize reform javnih zdravstvenih sistemov v Evropi in tretjih državah ter ocene njihovih srednjeročnih in dolgoročnih gospodarskih in družbenih vplivov.
Analyses of future health workforce needs both in terms of numbers and required skills in relation to new patterns of care will be supported.
Prav tako se bodo podpirale analize prihodnjih potreb po številu zdravstvenega osebja in potrebnih znanj v zvezi z novimi načini oskrbe.
Research on the evolution of health inequalities, on their interplay with other economic and social inequalities and on the effectiveness of policies aiming to reduce them in Europe and beyond will be supported.
Podpirale se bodo raziskave o razvoju neenakosti na področju zdravja in njihovem medsebojnem vplivu z drugimi gospodarskimi in socialnimi neenakostmi ter o učinkovitosti politik, katerih cilj je zmanjšanje teh razlik v Evropi in zunaj nje.
Finally, there is a need to support the assessment of patient safety solutions and quality assurance systems, including the role of patients.
Naposled je treba podpreti tudi ocenjevanje rešitev za varnost pacientov in sistemov zagotavljanja kakovosti, vključno z vlogo pacientov.
Implementation of this specific objective will include support for knowledge and technology transfer and other forms of dissemination, for large-scale piloting and demonstration actions, and for standardisation.
Izvajanje tega posebnega cilja bo vključevalo podporo za prenos znanja in tehnologij ter druge oblike širjenja, obsežne pilotne in predstavitvene dejavnosti ter standardizacijo.
In this way, market deployment of products and services will be accelerated, and scalable solutions for Europe and beyond will be validated.
Na ta način se bo pospešilo tržno uvajanje izdelkov in storitev ter se bodo potrdile obsežne rešitve za Evropo in zunaj nje.
Such actions will not only support European industrial competitiveness and the involvement of innovative SMEs but will require the active involvement of all stakeholders.
Takšni ukrepi ne bodo le podpirali evropske industrijske konkurenčnosti in sodelovanje malih in srednjih podjetij, temveč bo potrebna tudi dejavna vloga vseh zainteresiranih strani.
Synergies with other relevant programmes and activities, both public and private, at Union, national and international levels will be sought.
Iskale se bodo sinergije z drugimi ustreznimi programi in dejavnostmi, javnimi in zasebnimi, na ravni Unije ter na nacionalni in mednarodni ravni.
In particular, synergies with activities developed in the context of the Health for Growth Programme will be sought.
Iskale se bodo zlasti sinergije z dejavnostmi, razvitimi v okviru programa Zdravje za rast.
The Scientific Panel for Health will be a science-led stakeholder platform which elaborates scientific input concerning this societal challenge.
Znanstveni odbor za zdravje bo v znanost usmerjena platforma zainteresiranih strani, ki bo pripravljala znanstvene prispevke v zvezi s tem družbenim izzivom.
It will provide a coherent scientific focused analysis of research and innovation bottlenecks and opportunities related to this societal challenge, contribute to the definition of its research and innovation priorities, and encourage Union-wide scientific participation in it.
Odbor bo zagotovil celovito, znanstveno usmerjeno analizo s tem družbenim izzivom povezanih ovir in priložnosti za raziskave in inovacije, prispeval bo k opredelitvi z njim povezanih prednostnih nalog na področju raziskav in inovacij ter spodbujal udeležbo znanstvene skupnosti z vse Unije pri spopadanju s tem izzivom.
Through active cooperation with stakeholders, it will help to build capabilities and to foster knowledge sharing and stronger collaboration across the Union in this field.
Ob dejavnem sodelovanju zainteresiranih strani bo prispeval h krepitvi zmogljivosti ter spodbujanju izmenjave znanja in tesnejšega sodelovanja po vsej Evropi na tem področju.
Consideration may be given to support relevant Joint Programming Initiatives (JPIs) and relevant public-public and public-private partnerships.
Lahko bi se razmislilo o podpori za ustrezne pobude skupnega načrtovanja programov ter za ustrezna javno-javna in javno-zasebna partnerstva.
Appropriate links with the actions of relevant European Innovation Partnerships and the relevant aspects of the research and innovation agendas of European Technology Platforms will also be established.
Vzpostavljene bodo tudi primerne povezave z ukrepi ustreznih evropskih inovacijskih partnerstev in ustreznimi vidiki raziskovalnih in inovacijskih agend evropskih tehnoloških platform.
FOOD SECURITY, SUSTAINABLE AGRICULTURE AND FORESTRY, MARINE, MARITIME AND INLAND WATER RESEARCH, AND THE BIOECONOMY
PREHRANSKA VARNOST, TRAJNOSTNO KMETIJSTVO IN GOZDARSTVO, MORSKE IN POMORSKE RAZISKAVE TER RAZISKAVE CELINSKIH VODA IN BIOGOSPODARSTVO
Sustainable agriculture and forestry
Trajnostno kmetijstvo in gozdarstvo
Increasing production efficiency and coping with climate change, while ensuring sustainability and resilience
Povečanje učinkovitosti proizvodnje in obvladovanje posledic podnebnih sprememb ob zagotavljanju vzdržnosti in odpornosti
Activities will enhance productivity as well as the adaptive capacity of plants, animals and production systems to cope with rapidly changing environmental/climatic conditions and increasingly scarce natural resources.
Z dejavnostmi se bosta povečali produktivnost ter sposobnost prilagajanja rastlin, živali in proizvodnih sistemov pri obvladovanju hitro spreminjajočih se okoljskih in podnebnih razmer ter vse redkejših naravnih virov.
The resulting innovations will help to move towards a low energy, low emission and low waste economy and to reduce natural resources demand along the entire food and feed supply chain.
Iz tega izhajajoče inovacije bodo podlaga za prehod na gospodarstvo z nizko porabo energije, nizkimi emisijami in malo odpadki ter manjšim povpraševanjem po naravnih virih v celotni dobavni verigi hrane in krme.
In addition to contributing to food security, new opportunities will be created for the use of biomass and by-products from agriculture for a wide range of non-food applications.
Poleg tega, da prispevajo k prehranski varnosti, bodo ustvarile nove možnosti za uporabo biomase in stranskih proizvodov iz kmetijstva v raznovrstnih uporabah v neprehrambene namene.
Multi-disciplinary approaches will be sought to improve the performance of plants, animals and micro-organisms, while ensuring efficient resource use (water, land, soil, nutrients, energy and other inputs) and the ecological integrity of rural areas.
Da bi se izboljšalo delovanje rastlin, živali, mikroorganizmov, se bodo iskali večdisciplinarni pristopi, hkrati pa zagotovila učinkovita uporaba virov (vode, tal, prsti, hranilnih snovi, energije in drugih surovin) in ekološka celovitost podeželskih območij.
Emphasis will be placed on integrated and diverse production systems and agronomic practices, including the use of precision technologies and ecological intensification approaches to benefit both conventional and organic agriculture.
Poudarek bo na integriranih in raznovrstnih proizvodnih sistemih in agronomskih praksah, vključno z uporabo preciznih tehnologij in pristopov za ekološko okrepitev v korist konvencionalnega in ekološkega kmetijstva.
Also urban greening will be promoted, with new forms of agriculture, horticulture and forestry in urban and peri-urban areas.
Z novimi oblikami kmetijstva, hortikulture in gozdarstva v mestnih in primestnih območjih se bo spodbujal tudi razvoj bolj zelenih mestnih območij.